Massachusetts Defective Breast Mesh & Implant Injury Attorneys: Attorney911 (The Manginello Law Firm, PLLC) Brings Ralph Manginello’s 27+ Years of Federal Trial Experience to Massachusetts, Litigating Allergan BIOCELL Textured Implants (Recalled July 2019, MDL 2921 Before Judge Brian R. Martinotti, Bellwether October 19, 2026), Mentor MemoryGel, AlloDerm, Strattice and GalaFLEX P4HB Scaffolds — Lupe Peña is a Former Insurance Defense Attorney Conducting Consultations in Fluent Spanish, Handling Massachusetts’s 3-Year Statute of Limitations with Discovery-Rule Application for BIA-ALCL (CD30+/ALK-, T-Cell Receptor Monoclonality) and BIA-SCC Pathology — Federal Preemption Litigated Under Riegel, Lohr and Buckman Per 21 CFR Parts 803, 807 and 814 — $50M+ Recovered for Families Plus Active $10M Bermudez Litigation Featured on ABC13 and FOX 26 — Free 24/7 Consultation, No Fee Unless We Recover Compensation for You, Hablamos Español: 1-888-ATTY-911
Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Massachusetts: The Complete Guide for Women, Families, and Survivors For women across Massachusetts—from the specialized surgical suites of the Longwood Medical Area in Boston to the community health centers of Worcester and the reconstruction clinics in Springfield—the promise of modern breast surgery is often intertwined with hope. Whether you are a breast cancer survivor navigating the complex stages of reconstruction, a woman carrying a BRCA1 or BRCA2 mutation who chose a prophylactic mastectomy to save your life, or a cosmetic patient seeking a revision or augmentation, you were likely told that the materials used in your body were the gold standard of safety. The reality we see today in Massachusetts healthcare is far more troubling. Thousands of women are realizing that the surgical mesh, acellular dermal matrix (ADM), and bioabsorbable scaffolds implanted during their procedures were never formally proved safe for use in breast tissue by the FDA. Instead, these devices entered the market through a regulatory shortcut known as the 510(k) clearance pathway—a process that values "substantial equivalence" to older devices over actual clinical testing for specific surgeries. At The Manginello Law Firm, PLLC, operating under the…